The United States' top infectious disease scientist on Monday hailed early trial results from Moderna's Covid-19 vaccine as "stunningly impressive," and said the findings were an emphatic validation of experimental mRNA technology ...
Nov 17, 2020
0
3
US biotech firm Moderna on Monday announced its experimental vaccine against COVID-19 was almost 95 percent effective, marking a second major breakthrough in the quest to end the pandemic.
Nov 16, 2020
0
17
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from ...
Nov 13, 2020
0
184
A team of immunology experts from research organisations in Belgium and the UK have come together to apply their pioneering research methods to put individuals' COVID-19 response under the microscope. Published today in the ...
Nov 13, 2020
0
4
Certain body parts, such as the skin or liver, can repair themselves after damage. Cell regeneration is the phenomenon by which cells that are still functional proliferate to compensate for cellular damage. For the past 30 ...
Nov 12, 2020
0
36
In a study recently published in the journal Allergy, a team of MedUni Vienna scientists led by immunologist Winfried F. Pickl and allergologist Rudolf Valenta (both from the Center for Pathophysiology, Infectiology and Immunology) ...
Nov 2, 2020
0
13
Immune response is a balancing act: Too much can lead to inflammatory or autoimmune disease; too little could lead to a serious infection. Regulatory T cells, or Tregs, are important players in striking this balance, acting ...
Oct 26, 2020
0
28
New research in mice suggests that a high-fat diet early in life may impair male fertility in adulthood. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.
Oct 22, 2020
0
5
A gut hormone, ghrelin, is a key regulator of new nerve cells in the adult brain, a Swansea-led research team has discovered. It could help pave the way for new drugs to treat dementia in patients with Parkinson's Disease.
Oct 21, 2020
0
20
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
